Literature DB >> 19195889

The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.

James B Thomas1, Hernán Navarro, Keith R Warner, Brian Gilmour.   

Abstract

In a search for nonpeptide agonists for the neurotensin receptor (NTR1), we replaced the adamantyl amino acid moiety found in the antagonist SR48692 (1a) with leucine and related alpha-alkylamino acids found in peptide agonists. When tested in a calcium mobilization assay, we found that both d- and l-leucine confer partial agonist activity to the pyrazole scaffold with the l-enantiomer (3a) providing a significantly greater response. A brief SAR survey demonstrated that the observed agonist activity was resilient to changes made to the dimethoxyaryl ring in 3a. The resulting compounds were less potent relative to 3a but showed greater agonist responses. The partial agonist activity was extinguished when the chloroquinoline ring was replaced with naphthalene. Thus, while l-leucine appears to possess a powerful agonist directing affect for the NTR1 receptor, its presence alone in the molecular architecture is not sufficient to insure agonist behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195889      PMCID: PMC4418176          DOI: 10.1016/j.bmcl.2009.01.024

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  30 in total

1.  Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system.

Authors:  Philippe Sarret; Amélie Perron; Thomas Stroh; Alain Beaudet
Journal:  J Comp Neurol       Date:  2003-07-07       Impact factor: 3.215

Review 2.  Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.

Authors:  Patrick Kitabgi
Journal:  Curr Opin Drug Discov Devel       Date:  2002-09

Review 3.  Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems.

Authors:  R Quirion; W B Rowe; P A Lapchak; D M Araujo; A Beaudet
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

4.  The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach.

Authors:  Yi Fan; Margaret H Lai; Kelly Sullivan; Michael Popiolek; Terrance H Andree; Paul Dollings; Mark H Pausch
Journal:  Bioorg Med Chem Lett       Date:  2008-09-24       Impact factor: 2.823

5.  Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.

Authors:  S Barroso; F Richard; D Nicolas-Ethève; J L Reversat; J M Bernassau; P Kitabgi; C Labbé-Jullié
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

Review 6.  Distribution of neurotensin and its receptor in the central nervous system.

Authors:  G R Uhl
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens.

Authors:  Ko-Woon Lee; Yong Kim; Amie M Kim; Kathryn Helmin; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

8.  Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Authors:  J Mazella; J M Botto; E Guillemare; T Coppola; P Sarret; J P Vincent
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

9.  The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor.

Authors:  J Mazella; N Zsürger; V Navarro; J Chabry; M Kaghad; D Caput; P Ferrara; N Vita; D Gully; J P Maffrand; J P Vincent
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

10.  Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling.

Authors:  Seiichiro Matsuyama; Ryuichi Fukui; Hideho Higashi; Akinori Nishi
Journal:  Eur J Neurosci       Date:  2003-09       Impact factor: 3.386

View more
  8 in total

1.  Imidazole-derived agonists for the neurotensin 1 receptor.

Authors:  Paul M Hershberger; Michael P Hedrick; Satyamaheshwar Peddibhotla; Arianna Mangravita-Novo; Palak Gosalia; Yujie Li; Wilson Gray; Michael Vicchiarelli; Layton H Smith; Thomas D Y Chung; James B Thomas; Marc G Caron; Anthony B Pinkerton; Lawrence S Barak; Gregory P Roth
Journal:  Bioorg Med Chem Lett       Date:  2013-11-21       Impact factor: 2.823

2.  Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.

Authors:  Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick R Maloney; Yujie Li; Monika Milewski; Palak Gosalia; Wilson Gray; Alka Mehta; Eliot Sugarman; Becky Hood; Eigo Suyama; Kevin Nguyen; Susanne Heynen-Genel; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Gregory P Roth; Layton H Smith; Thomas D Y Chung; Glen R Hanson; James B Thomas; Marc G Caron; Lawrence S Barak; Anthony B Pinkerton
Journal:  ACS Med Chem Lett       Date:  2013-07-20       Impact factor: 4.345

3.  Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.

Authors:  Anthony B Pinkerton; Satyamaheshwar Peddibhotla; Fusayo Yamamoto; Lauren M Slosky; Yushi Bai; Patrick Maloney; Paul Hershberger; Michael P Hedrick; Bekhi Falter; Robert J Ardecky; Layton H Smith; Thomas D Y Chung; Michael R Jackson; Marc G Caron; Lawrence S Barak
Journal:  J Med Chem       Date:  2019-08-20       Impact factor: 7.446

4.  Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.

Authors:  James B Thomas; Angela M Giddings; Srinivas Olepu; Robert W Wiethe; Danni L Harris; Sanju Narayanan; Keith R Warner; Philippe Sarret; Jean-Michel Longpre; Scott P Runyon; Brian P Gilmour
Journal:  Bioorg Med Chem Lett       Date:  2014-11-24       Impact factor: 2.823

5.  The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).

Authors:  Paolo Di Fruscia; Yuanjun He; Marcel Koenig; Sahba Tabrizifard; Ainhoa Nieto; Patricia H McDonald; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2014-06-20       Impact factor: 2.823

6.  Discovery of a novel small molecule agonist scaffold for the APJ receptor.

Authors:  Sanju Narayanan; Rangan Maitra; Jeffery R Deschamps; Katherine Bortoff; James B Thomas; Yanyan Zhang; Keith Warner; Vineetha Vasukuttan; Ann Decker; Scott P Runyon
Journal:  Bioorg Med Chem       Date:  2016-06-11       Impact factor: 3.641

7.  Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound.

Authors:  James B Thomas; Angela M Giddings; Robert W Wiethe; Srinivas Olepu; Keith R Warner; Philippe Sarret; Louis Gendron; Jean-Michel Longpre; Yanan Zhang; Scott P Runyon; Brian P Gilmour
Journal:  J Med Chem       Date:  2014-06-05       Impact factor: 7.446

8.  Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism.

Authors:  Mattia Deluigi; Alexander Klipp; Christoph Klenk; Lisa Merklinger; Stefanie A Eberle; Lena Morstein; Philipp Heine; Peer R E Mittl; Patrick Ernst; Theodore M Kamenecka; Yuanjun He; Santiago Vacca; Pascal Egloff; Annemarie Honegger; Andreas Plückthun
Journal:  Sci Adv       Date:  2021-01-27       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.